Photomedicine Devices And Technologies Market Size, Share & Trends Analysis Report By Product (Dermatology, Wound healing Pain management, Optical diagnostics, Oncology), By Technology, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Pharmerging Market Growth & Trends
The global pharmerging market size is expected to reach USD 2.08 trillion in 2030 and is projected to grow at a CAGR of 2.6% from 2024 to 2030. This market is expected to grow due to the increasing geriatric population, increasing disease burden of chronic disorders, and increasing healthcare expenditure.
According to the United Nations (UN), the number of people above the age of 60 years is estimated to be 901 million in 2015. The increasing geriatric population boosts the demand for better treatment options for chronic diseases such as hyperlipidemia, hypertension, cancer, dementia, congestive heart failure. According to a study conducted by Deloitte in 2011, the geriatric population accounts for almost 23.0-40.0% of the prescription drug market, and 40.0-50.0% of the OTC drug market. Another driving factor for the pharmerging market is increasing healthcare expenditure.
The increasing disease burden of chronic diseases in developing countries is boosting growth in the market. According to the Global Health Observatory data, in 2015, 70.0% of the deaths were due to non-communicable diseases (NCD). The major NCDs are cardiovascular diseases (CVD) which caused 45.0% of all NCD deaths, cancer which caused 22.0% of all NCD deaths and chronic obstructive pulmonary disease (COPD) which causes 10.0% of all NCD deaths, and diabetes which caused 4.0% of all NCD deaths.
Pharmerging Market Report Highlights
Pharmerging Market Growth & Trends
The global pharmerging market size is expected to reach USD 2.08 trillion in 2030 and is projected to grow at a CAGR of 2.6% from 2024 to 2030. This market is expected to grow due to the increasing geriatric population, increasing disease burden of chronic disorders, and increasing healthcare expenditure.
According to the United Nations (UN), the number of people above the age of 60 years is estimated to be 901 million in 2015. The increasing geriatric population boosts the demand for better treatment options for chronic diseases such as hyperlipidemia, hypertension, cancer, dementia, congestive heart failure. According to a study conducted by Deloitte in 2011, the geriatric population accounts for almost 23.0-40.0% of the prescription drug market, and 40.0-50.0% of the OTC drug market. Another driving factor for the pharmerging market is increasing healthcare expenditure.
The increasing disease burden of chronic diseases in developing countries is boosting growth in the market. According to the Global Health Observatory data, in 2015, 70.0% of the deaths were due to non-communicable diseases (NCD). The major NCDs are cardiovascular diseases (CVD) which caused 45.0% of all NCD deaths, cancer which caused 22.0% of all NCD deaths and chronic obstructive pulmonary disease (COPD) which causes 10.0% of all NCD deaths, and diabetes which caused 4.0% of all NCD deaths.
Pharmerging Market Report Highlights
- The pharmaceutical product segment dominated the market and accounted for the largest revenue share of 85.0% in 2023.
- The tier-1 economy led the market, accounting for the largest market share at 60.5% in 2023.
- The key strategic initiatives include new product launches, acquisitions and mergers, and collaborations.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Photomedicine Devices & Technologies Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Photomedicine Devices & Technologies Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Dermatology
4.3.1. Dermatology Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.3.1.1. Tattoo removal
4.3.1.2. Hair removal
4.3.1.3. Skin resurfacing
4.4. Wound Healing
4.4.1. Wound Healing Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5. Pain Management
4.5.1. Pain Management Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.6. Oncology
4.6.1. Oncology Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.7. Optical Diagnostics
4.7.1. Optical Diagnostics Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.8. Dental Procedures
4.8.1. Dental Procedures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 5. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Photomedicine Devices & Technologies Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Laser
5.3.1. Laser Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. Polychromatic Polarized Light
5.4.1. Polychromatic Polarized Light Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5. Full Spectrum Light
5.5.1. Full Spectrum Light Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6. Dichroic Lamps
5.6.1. Dichroic Lamps Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.7. Light Emitting Diodes
5.7.1. Light Emitting Diodes Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 6. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Photomedicine Devices & Technologies Market Share, By Region, 2023 & 2030, USD Million
6.2. North America
6.2.1. North America Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Galderma
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Lumenis
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. THOR Photomedicine Ltd
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Alma Lasers Ltd.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. QBMI Photomedicine
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. AngioDynamics
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. PhotoMedex, Inc.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. IRIDEX Corporation
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Spectranetics
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Syneron Medical Ltd.
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. Candela
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Photomedicine Devices & Technologies Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Photomedicine Devices & Technologies Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Dermatology
4.3.1. Dermatology Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.3.1.1. Tattoo removal
4.3.1.2. Hair removal
4.3.1.3. Skin resurfacing
4.4. Wound Healing
4.4.1. Wound Healing Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5. Pain Management
4.5.1. Pain Management Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.6. Oncology
4.6.1. Oncology Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.7. Optical Diagnostics
4.7.1. Optical Diagnostics Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.8. Dental Procedures
4.8.1. Dental Procedures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 5. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Photomedicine Devices & Technologies Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Laser
5.3.1. Laser Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. Polychromatic Polarized Light
5.4.1. Polychromatic Polarized Light Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5. Full Spectrum Light
5.5.1. Full Spectrum Light Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6. Dichroic Lamps
5.6.1. Dichroic Lamps Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.7. Light Emitting Diodes
5.7.1. Light Emitting Diodes Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 6. PHOTOMEDICINE DEVICES & TECHNOLOGIES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Photomedicine Devices & Technologies Market Share, By Region, 2023 & 2030, USD Million
6.2. North America
6.2.1. North America Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. France Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Photomedicine Devices & Technologies Market Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Galderma
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Lumenis
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. THOR Photomedicine Ltd
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Alma Lasers Ltd.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. QBMI Photomedicine
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. AngioDynamics
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. PhotoMedex, Inc.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. IRIDEX Corporation
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Spectranetics
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Syneron Medical Ltd.
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. Candela
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
